Janney Montgomery Scott LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Janney Montgomery Scott LLC

  • $35.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022
BUY
$144.95 - $152.29 $4,783 - $5,025
33 Added 0.96%
3,454 $522,000
Q2 2022

Aug 03, 2022
BUY
$83.14 - $145.99 $123,379 - $216,649
1,484 Added 76.61%
3,421 $497,000
Q1 2022

May 04, 2022
BUY
$110.08 - $142.92 $7,375 - $9,575
67 Added 3.58%
1,937 $230,000
Q4 2021

Jan 27, 2022
SELL
$99.73 - $148.48 $20,943 - $31,180
-210 Reduced 10.1%
1,870 $258,000
Q3 2021

Oct 29, 2021
BUY
$98.85 - $138.91 $205,608 - $288,932
2,080 New
2,080 $289,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email